Latest Feature

Sequent Medical CEO Wilder bets on braids

Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pus

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

InfoBionic raises $17m for cloud-based patient monitoring system

November 24, 2014 by Mark Hollmer

InfoBionic closes the 2nd tranche of its $17 million Series B financing, attracting interest from Excel Venture Management and a Blue Cross Blue Shield subsidiary.

InfoBionic raises $17m for could-based patient monitoring system

An investment subsidiary of Blue Cross Blue Shield of Massachusetts signed on for the 2nd tranche of InfoBionic's $17 million Series B financing. The Lowell, Mass.-based startup plans to use the cash infusion to commercialize its cloud-based remote patient monitoring system in the U.S. and Europe.

FDA approves Avantis Third Eye Panoramic colonoscopy device

November 24, 2014 by Val Kennedy

The FDA approves Avantis Medical Systems' Third Eye Panoramic digital imaging device for colonoscopies.

FDA approves Avantis Third Eye Panoramic colonoscopy device

Avantis Medical Systems said the FDA approved its Third Eye Panoramic digital imaging device for colonoscopies.

Pelvic mesh trial losses pressure Boston Scientific

November 24, 2014 by MassDevice

Back-to-back losses in pelvic mesh lawsuits could drive up the cost – and urgency – of settling thousands of other such cases for Boston Scientific, legal experts say.

Pelvic mesh trial losses pressure Boston Scientific

BrainScope wins FDA clearance for Ahead 100 brain-injury scanner

November 21, 2014 by Val Kennedy

BrainScope wins U.S. regulatory clearance for its Ahead 100 device for detecting traumatic brain injury.

BrainScope wins FDA approval for Ahead 100 brain-injury scanner

BrainScope said it won 510(k) clearance from the FDA for its Ahead 100 device, designed to detect traumatic brain injury.

Covidien wins home-use CE Mark for Nellcor oxygen monitor

November 21, 2014 by Val Kennedy

Covidien says it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Covidien wins CE Mark for Nellcor oxygen monitor

Covidien (NYSE:COV) said it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp